Cancer News and Research

Latest Cancer News and Research

Mass. hospitals oppose state penalties for preventable readmissions

Also in state news, a California news outlet reports on the difficult challenge hospitals face trying to recover overdue bill in a tough economy and another looks at efforts by a handful of hospitals to partner with churches to help reduce health care costs.

22 Sep 2011

New Poll: 9 out of 10 Ontarians would support an investment in lung health

According to a new Leger Marketing poll conducted for the Ontario Lung Association, 9 out of 10 of Ontarians would support the Ontario government investing in lung health today if it would save future healthcare spending.

22 Sep 2011

New and better understanding of blood vessel growth and angiogenesis in cancer

A new and better understanding of blood vessel growth and vascular development (angiogenesis) in cancer has been made possible by research carried out by a team of scientists from Moffitt Cancer Center, the University of Florida, Harvard University, Yale University and the Children's Hospital of Los Angeles.

22 Sep 2011

Mayo Clinic to develop Global Smoke-Free Worksite Challenge

Mayo Clinic announced today at the annual Clinton Global Initiative (CGI) meeting in New York City its partnership with other organizations to develop a Global Smoke-Free Worksite Challenge.

22 Sep 2011

Zymeworks announces completion of $8.1M financing

Zymeworks Inc., a privately held biotherapeutics company focused on the development of best-in-class antibody and next generation protein-based therapeutics, today announced the completion of a financing totaling $8.1 million.

22 Sep 2011

MD Anderson professor wins 2011 Julie and Ben Rogers Award for Excellence in Prevention

Lorna McNeill, Ph.D., assistant professor in the Department of Health Disparities Research at The University of Texas MD Anderson Cancer Center, is the recipient of the 2011 Julie and Ben Rogers Award for Excellence in Prevention.

22 Sep 2011

Virginia G. Piper, TGen and Scottsdale Healthcare begin AP26113 Phase 1 study in NSCLC

Patients at Virginia G. Piper Cancer Center Clinical Trials are the first in the nation to participate in a clinical trial to determine the safety, tolerability and preliminary activity of an investigational drug that targets cell-signaling proteins associated with the most common form of lung cancer, as well as other forms of cancer such as lymphomas and neuroblastoma.

22 Sep 2011

HSPH receives CDC grant to evaluate HIV combination prevention initiative in Botswana

A new four-year, $20 million grant from the U.S. Centers for Disease Control and Prevention (CDC) will enable Harvard School of Public Health (HSPH) researchers to evaluate the impact and cost-effectiveness of a unique combination of HIV prevention strategies in Botswana.

22 Sep 2011

Methylphenidate drug may induce arousal from general anesthesia

Administration of the commonly used stimulant drug methylphenidate (Ritalin) was able to speed recovery from general anesthesia in an animal study conducted at Massachusetts General Hospital.

22 Sep 2011

Stanford Hospital & Clinics inaugurates new Brain Tumor Center

Today, Stanford Hospital & Clinics inaugurates its new Brain Tumor Center, framing its considerable corps of top-notch specialists into a treatment team driven by expertise, experience and compassion.

22 Sep 2011

Theraclone initiates TCN-032 Phase 1 trial in influenza A

Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today first dosing of subjects in a Phase 1 clinical trial of TCN-032, a broadly protective, fully human monoclonal antibody for the treatment of influenza A virus.

22 Sep 2011

Early ART can be cost-effective and decrease mortality in HIV patients

Researchers at Weill Cornell Medical College and GHESKIO have shown that early treatment of HIV not only saves lives but is also cost-effective. Results are published in today's edition of PLoS Medicine.

22 Sep 2011

NEJM publishes Boehringer Ingelheim's BIBF 1120 phase II trial on IPF

Boehringer Ingelheim's investigational tyrosine kinase inhibitor (TKI) BIBF 1120 demonstrated a positive trend in reducing lung function decline in patients with idiopathic pulmonary fibrosis (IPF), according to phase II clinical trial results published today online in the New England Journal of Medicine.

22 Sep 2011

Sanofi-aventis sponsors People vs. Cancer initiative

Sanofi-aventis Canada is proud to be the national sponsor of People vs. Cancer, a speaking tour of three Canadian universities featuring Stephen Lewis, former Canadian Ambassador to the United Nations and United Nations Special Envoy for HIV/AIDS in Africa.

22 Sep 2011

Peptide receptor radiolabeled therapy shows promise against neuroendocrine tumors

According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate), is effective not only in decreasing tumor size but also in reducing the severity of side effects that often accompany a cancer diagnosis.

22 Sep 2011

Three Johns Hopkins scientists receive NIH Director's New Innovator Awards

A pioneer in the field of epigenetics who has been spearheading the use of genome-wide technology for epigenetics research, a researcher who has revealed a weakness in the tuberculosis bacterium that makes it more susceptible to antibiotics, and a scientist who seeks to revolutionize new methods for toxicological testing to improve human health and reduce animal testing have received Director's Awards from the National Institutes of Health.

22 Sep 2011

John Theurer Cancer Center to join MMRF's Personalized Medicine Initiative

The John Theurer Cancer Center at Hackensack University Medical Center, a top 50 U.S. News best hospital for cancer, is one of the first four clinical sites enrolling patients in a landmark study designed to uncover the molecular segments and variations of multiple myeloma.

22 Sep 2011

NIH-funded project to develop new class of tissue regeneration therapeutics

The National Institutes of Health (NIH) has awarded nearly $2 million to researchers at the Georgia Institute of Technology and Emory University to develop a new class of therapeutics for treating traumatic injuries and degenerative diseases.

22 Sep 2011

Scientists identify stress receptor that stimulates growth and migration of cancer cells

It's a common belief that there's a link between chronic stress and an increased risk of cancer. In new research published online by the International Journal of Cancer, scientists at The University of Western Ontario have taken a step toward confirming that belief.

22 Sep 2011

Viewpoints: Progressives relish fight for 'shared sacrifice;' Desmond Tutu seeks to renew battle against HIV

To get our books in order, Obama would raise taxes on the rich while gaining savings by ending the wars abroad and reducing Medicare and Medicaid's unnecessarily high payments to drug companies. Republicans rise in defense of tax cuts for the wealthy and insist that deficit reduction come solely from cuts in Social Security, Medicare and Medicaid and other "entitlements." The president stands for shared sacrifice; the Republicans for sheltering the privileged few. Progressives will have no problem standing with the president in this fight.

22 Sep 2011

Cancer News and Research

Latest Cancer News and Research

Mass. hospitals oppose state penalties for preventable readmissions

New Poll: 9 out of 10 Ontarians would support an investment in lung health

New and better understanding of blood vessel growth and angiogenesis in cancer

Mayo Clinic to develop Global Smoke-Free Worksite Challenge

Zymeworks announces completion of $8.1M financing

MD Anderson professor wins 2011 Julie and Ben Rogers Award for Excellence in Prevention

Virginia G. Piper, TGen and Scottsdale Healthcare begin AP26113 Phase 1 study in NSCLC

HSPH receives CDC grant to evaluate HIV combination prevention initiative in Botswana

Methylphenidate drug may induce arousal from general anesthesia

Stanford Hospital & Clinics inaugurates new Brain Tumor Center

Theraclone initiates TCN-032 Phase 1 trial in influenza A

Early ART can be cost-effective and decrease mortality in HIV patients

NEJM publishes Boehringer Ingelheim's BIBF 1120 phase II trial on IPF

Sanofi-aventis sponsors People vs. Cancer initiative

Peptide receptor radiolabeled therapy shows promise against neuroendocrine tumors

Three Johns Hopkins scientists receive NIH Director's New Innovator Awards

John Theurer Cancer Center to join MMRF's Personalized Medicine Initiative

NIH-funded project to develop new class of tissue regeneration therapeutics

Scientists identify stress receptor that stimulates growth and migration of cancer cells

Viewpoints: Progressives relish fight for 'shared sacrifice;' Desmond Tutu seeks to renew battle against HIV

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in